Loperamide Toxicity in a Collie with the MDR1 Mutation Associated with Ivermectin Sensitivity

Journal of Veterinary Internal Medicine

Volumn 18, Issue 1, 2004, Pages 117-118

  Sartor, Laura L ^a   Bentjen, Steven A ^b   Trepanier, Lauren ^a   Mealey, Katrina L ^b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIARRHEAL AGENT; CYCLOSPORIN A; DOXORUBICIN; IVERMECTIN; LOPERAMIDE; METOCLOPRAMIDE; VINCRISTINE;

ARTICLE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM DISEASE; DRUG INTOXICATION; FEMALE; FLUID TRANSPORT; GENE MUTATION; HYPERSALIVATION; HYPOKALEMIA; LABORATORY TEST; MDR 1 GENE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NONHUMAN; PHYSICAL EXAMINATION; VOMITING;

ANIMALS; ANTIDIARRHEALS; DIAGNOSIS, DIFFERENTIAL; DOG DISEASES; DOGS; DRUG TOXICITY; FEMALE; GENE DELETION; GENES, MDR; LOPERAMIDE; PEDIGREE;

EID: 0842330472     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2004)18<117:LTIACW>2.0.CO;2     Document Type: Article

References (12)

1. Hugnet C, Cadore JL, Buronfosse F, et al. Loperamide poisoning in the dog. Vet Hum Toxicol 1996;38:31-33.
2. Schinkel AH, Wagenaar E, Mol CA, van Deemter L. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. J Clin Invest 1996;91:2517-2524.
3. van Tellingen O. The importance of drug-transporting P-glycoproteins in toxicology. Toxicol Lett 2001;120:31-41.
4. Fromm MF. P-glycoprotein: A defense mechanism limiting oral bioavailability and CNS accumulation of drugs. Int J Clin Pharmacol Ther 2000;38:69-74.
5. Sakaeda T, Nakamura T, Okumura K. MDR1 genotype-related pharmacokinetics and pharmacodynamics. Biol Pharm Bull 2002;25: 1391-1400.
6. Wandel C, Kim R, Wood M, Wood A. Interaction of morphine, fentanyl, sufentanil, alfentanil, and loperamide with the efflux drug transporter P-glycoprotein. Anesthesiology 2002;96:913-920.
7. Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in Collies is associated with a deletion mutation of the mdr1 gene. Pharmacogenetics 2001;11:727-733.
8. Mealey KL, Bentjen SA, Waiting DK. Frequency of the mutant MDR1 allele associated with ivermectin sensitivity in a sample population of Collies from the northwestern United States. Am J Vet Res 2002;63:479-481.
9. Sadeque AJ, Wandel C, He H, et al. Increased drug delivery to the brain by P-glycoprotein inhibition. Clin Pharmacol Ther 2000;68: 231-237.
10. Nelson OL, Carsten E, Bentjen SA, Mealey KL. Ivermectin toxicity in an Australian Shepherd Dog with the MDR1 mutation associated with ivermectin sensitivity in Collies. J Vet Intern Med 2003; 17:354-356.
11. Jaffe JH, Kanzler M, Green J. Abuse potential of loperamide. J Clin Pharmacol Ther 1980;28:812-819.
12. Ericsson CD, Johnson PC. Safety and efficacy of loperamide. Am J Med 1990;88:10S-14S.